Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 9,234 | 9,485 | 9,617 | 8,727 | 9,151 |
| Cost of Goods | 2,430 | 2,819 | 2,803 | 2,520 | 2,896 |
| Gross Profit | 6,803 | 6,666 | 6,814 | 6,208 | 6,254 |
| Operating Expenses | 11,619 | 10,347 | 11,232 | 10,615 | 10,546 |
| Operating Income | -4,385 | -2,862 | -3,615 | -3,887 | -3,396 |
| Interest Expense | 746 | 645 | 616 | 605 | 624 |
| Other Income | -366 | -64 | 6,178 | 3,014 | -5,239 |
| Pre-tax Income | -5,497 | -3,571 | 1,947 | -1,478 | -9,259 |
| Income Tax | N/A | -401 | N/A | N/A | N/A |
| Net Income Continuous | -5,497 | -3,170 | 1,947 | -1,478 | -7,568 |
| Net Income | $-5,497 | $-3,170 | $1,947 | $-1,478 | $-7,568 |
| EPS Basic Total Ops | -0.09 | -0.05 | 0.03 | -0.02 | -0.14 |
| EPS Basic Continuous Ops | -0.09 | -0.05 | 0.03 | -0.02 | -0.14 |
| EPS Diluted Total Ops | -0.09 | -0.05 | 0.03 | -0.02 | -0.14 |
| EPS Diluted Continuous Ops | -0.09 | -0.05 | 0.03 | -0.02 | -0.14 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.04 | -0.05 | -0.06 | -0.03 |
| EBITDA(a) | $-3,751 | $-2,271 | $-2,984 | $-3,292 | $-2,780 |